{"transactions":[{"id":837190,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-18T01:00:33.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The Reporting Person is exercising this option due, in part, to its near-term expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options vested in twenty-four equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":23837,"derivative":{"exercise_price":3.66,"expiration_date":"2027-06-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-26-009900","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126009900/form4.xml","form_type":"4"}},{"id":837189,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-18T01:00:33.000Z","date":"2026-03-17","kind":"gift","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved the Reporting Person's gift of 30,000 shares of Issuer common stock to the Lawrence P Guiheen Irrevocable Trust DTD 9/20/19, Arlene Guiheen TTEE, Katherine M Guiheen TTEE (the \"2019 Guiheen Irrevocable Trust\"), over which Mr. Guiheen retains control. The Reporting Person disclaims beneficial ownership of the securities held by the 2019 Guiheen Irrevocable Trust, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Includes 30,000 shares of common stock held in the 2019 Guiheen Irrevocable Trust."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001140361-26-009900","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126009900/form4.xml","form_type":"4"}},{"id":837188,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-18T01:00:33.000Z","date":"2026-03-17","kind":"gift","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved the Reporting Person's gift of 30,000 shares of Issuer common stock to the Lawrence P Guiheen Irrevocable Trust DTD 9/20/19, Arlene Guiheen TTEE, Katherine M Guiheen TTEE (the \"2019 Guiheen Irrevocable Trust\"), over which Mr. Guiheen retains control. The Reporting Person disclaims beneficial ownership of the securities held by the 2019 Guiheen Irrevocable Trust, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; and (ii) 94,830 shares of common stock owned by the Reporting Person."}],"balance_after":105520,"source":{"system":"sec-edgar","filing":"0001140361-26-009900","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126009900/form4.xml","form_type":"4"}},{"id":837187,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-03-18T01:00:33.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":30000,"price":3.66,"value":109800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; and (ii) 94,830 shares of common stock owned by the Reporting Person."}],"balance_after":135520,"source":{"system":"sec-edgar","filing":"0001140361-26-009900","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126009900/form4.xml","form_type":"4"}},{"id":909602,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T02:00:11.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":17730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":17730,"derivative":{"exercise_price":16.37,"expiration_date":"2036-02-09","underlying":"Common Stock","underlying_shares":17730},"source":{"system":"sec-edgar","filing":"0001140361-26-004886","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126004886/form4.xml","form_type":"4"}},{"id":909601,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-02-12T02:00:11.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":10690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; (ii) 5,445 RSUs out of 10,889 RSUs granted on February 19, 2025, which will vest fully on February 19, 2026, subject to the Reporting Person's continued service as of such vesting date; and (iii) 89,385 shares of common stock owned by the Reporting Person."}],"balance_after":105520,"source":{"system":"sec-edgar","filing":"0001140361-26-004886","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126004886/form4.xml","form_type":"4"}},{"id":1114685,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-12T01:00:21.000Z","date":"2025-06-09","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":20.96,"value":419200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes, as of the transaction date, (i) 10,889 restricted stock units granted on February 19, 2025, which vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of such vesting date; and (ii) 83,941 shares of common stock owned by the Reporting Person."}],"balance_after":94830,"source":{"system":"sec-edgar","filing":"0001140361-25-022240","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125022240/form4.xml","form_type":"4"}},{"id":1134879,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-24T01:00:30.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":false,"shares":1221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The Reporting Person is exercising this option due, in part, to its near-term expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options were granted on January 28, 2016 and vested in twenty-four equal monthly installments, becoming fully vested on January 28, 2018."}],"balance_after":0,"derivative":{"exercise_price":5.96,"expiration_date":"2026-01-28","underlying":"Common Stock","underlying_shares":1221},"source":{"system":"sec-edgar","filing":"0001140361-25-020376","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125020376/form4.xml","form_type":"4"}},{"id":1134878,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-24T01:00:30.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":false,"shares":7779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The Reporting Person is exercising this option due, in part, to its near-term expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options were granted on January 28, 2016 and vested in twenty-four equal monthly installments, becoming fully vested on January 28, 2018."}],"balance_after":1221,"derivative":{"exercise_price":5.96,"expiration_date":"2026-01-28","underlying":"Common Stock","underlying_shares":7779},"source":{"system":"sec-edgar","filing":"0001140361-25-020376","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125020376/form4.xml","form_type":"4"}},{"id":1134877,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-24T01:00:30.000Z","date":"2025-05-22","kind":"sale","planned":false,"acquired":false,"shares":1221,"price":20.12,"value":24566.52,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 10,889 restricted stock units granted on February 19, 2025, which vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of such vesting date; and (ii) 103,941 shares of common stock owned by the Reporting Person.  The number of common shares reported includes a de minimis reduction by 10 shares from the amount previously reported due to a broker adjustment."}],"balance_after":114830,"source":{"system":"sec-edgar","filing":"0001140361-25-020376","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125020376/form4.xml","form_type":"4"}},{"id":1134876,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-24T01:00:30.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":true,"shares":1221,"price":5.96,"value":7277.16,"ownership":{"direct":true},"balance_after":116051,"source":{"system":"sec-edgar","filing":"0001140361-25-020376","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125020376/form4.xml","form_type":"4"}},{"id":1134875,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-24T01:00:30.000Z","date":"2025-05-21","kind":"sale","planned":false,"acquired":false,"shares":7779,"price":20.32,"value":158069.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.73. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4."}],"balance_after":114830,"source":{"system":"sec-edgar","filing":"0001140361-25-020376","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125020376/form4.xml","form_type":"4"}},{"id":1134874,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-24T01:00:30.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":true,"shares":7779,"price":5.96,"value":46362.84,"ownership":{"direct":true},"balance_after":122609,"source":{"system":"sec-edgar","filing":"0001140361-25-020376","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125020376/form4.xml","form_type":"4"}},{"id":1252445,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-02-22T02:05:31.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":16279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":16279,"derivative":{"exercise_price":16.07,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":16279},"source":{"system":"sec-edgar","filing":"0001140361-25-005542","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125005542/form4.xml","form_type":"4"}},{"id":1252444,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-22T02:05:31.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":10889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 10,889 RSUs granted on February 19, 2025 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 12,020 restricted stock units granted on February 26, 2024, which will vest fully on February 26, 2025, subject to the Reporting Person's continued service as of such vesting date; and (iii) 141,921 shares of common stock owned by the Reporting Person."}],"balance_after":164830,"source":{"system":"sec-edgar","filing":"0001140361-25-005542","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036125005542/form4.xml","form_type":"4"}},{"id":1409515,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-12T01:00:24.000Z","date":"2024-09-09","kind":"exercise","planned":false,"acquired":false,"shares":9000,"price":10.8,"value":97200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The Reporting Person is exercising these options due, in part, to their near-term expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were granted on January 30, 2015 and vested in twenty-four equal monthly installments, becoming fully vested on January 30, 2017."}],"balance_after":0,"derivative":{"exercise_price":10.8,"expiration_date":"2025-01-30","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-24-040872","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124040872/form4.xml","form_type":"4"}},{"id":1409514,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-12T01:00:24.000Z","date":"2024-09-09","kind":"sale","planned":false,"acquired":false,"shares":9000,"price":18.4654,"value":166188.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $18.465 to $18.47. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 12,020 restricted stock units granted on February 26, 2024, which will vest fully on February 26, 2025, subject to the Reporting Person's continued service as of such vesting date; and (ii) 141,921 shares of common stock owned by the Reporting Person."}],"balance_after":153941,"source":{"system":"sec-edgar","filing":"0001140361-24-040872","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124040872/form4.xml","form_type":"4"}},{"id":1409513,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-12T01:00:24.000Z","date":"2024-09-09","kind":"exercise","planned":false,"acquired":true,"shares":9000,"price":10.8,"value":97200.0,"ownership":{"direct":true},"balance_after":162941,"source":{"system":"sec-edgar","filing":"0001140361-24-040872","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124040872/form4.xml","form_type":"4"}},{"id":1611845,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-02-29T02:00:43.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":37541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":37541,"derivative":{"exercise_price":5.4,"expiration_date":"2034-02-26","underlying":"Common Stock","underlying_shares":37541},"source":{"system":"sec-edgar","filing":"0001140361-24-010240","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124010240/form4.xml","form_type":"4"}},{"id":1611844,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-29T02:00:43.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":24040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 24,040 RSUs granted on February 26, 2024 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 25,815 RSUs granted on March 6, 2023 which will vest in full on March 6, 2024; and (iii) 104,086 shares of common stock owned by the reporting person."}],"balance_after":153941,"source":{"system":"sec-edgar","filing":"0001140361-24-010240","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124010240/form4.xml","form_type":"4"}},{"id":1962761,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-09T02:30:39.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":51630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":51630,"derivative":{"exercise_price":3.35,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":51630},"source":{"system":"sec-edgar","filing":"0001140361-23-010770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123010770/form4.xml","form_type":"4"}},{"id":1962760,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-03-09T02:30:39.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":25815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 13,293 RSUs granted on March 7, 2022, which will vest in full on March 7, 2023; and (iii) 90,793 shares of common stock owned by the reporting person."}],"balance_after":129901,"source":{"system":"sec-edgar","filing":"0001140361-23-010770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123010770/form4.xml","form_type":"4"}},{"id":2341315,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-09T22:59:00.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":53172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":53172,"derivative":{"exercise_price":1.67,"expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":53172},"source":{"system":"sec-edgar","filing":"0001140361-22-008675","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036122008675/form4.xml","form_type":"4"}},{"id":2341314,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-09T22:59:00.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":26586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 77,500 shares of common stock owned by the reporting person."}],"balance_after":104086,"source":{"system":"sec-edgar","filing":"0001140361-22-008675","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000114036122008675/form4.xml","form_type":"4"}},{"id":2825629,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T02:04:07.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in twelve equal monthly installments, becoming fully vested on February 25, 2022."}],"balance_after":55000,"derivative":{"exercise_price":2.35,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001193805-21-000297","document":"e620332_4-guiheen.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380521000297/e620332_4-guiheen.xml","form_type":"4"}},{"id":3165062,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-01T21:10:53.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Subsequent to the filing of the initial Form 4 by the Reporting Person on March 3, 2020, the Board of Directors of the Issuer corrected the vesting schedule of the RSUs. The RSUs will vest in two equal installments, on the six- and 12-month anniversaries of the grant, becoming fully vested on the one-year anniversary of the grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 7,500 RSUs granted on February 28, 2020 and reported on this Form 4, subject to vesting as set forth in footnote (1) and will be settled into common stock upon vesting; and (ii) 70,000 shares of common stock owned by the reporting person."}],"balance_after":77500,"source":{"system":"sec-edgar","filing":"0001193805-20-000550","document":"e619596_4a-guiheen.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520000550/e619596_4a-guiheen.xml","form_type":"4/A","original_submission_date":"2020-03-03"}},{"id":3231184,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-04T00:10:24.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":2.915,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-20-000289","document":"e619423_4-guiheen.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/e619423_4-guiheen.xml","form_type":"4"}},{"id":3231183,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-04T00:10:24.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"), which will vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 7,500 RSUs granted on February 28, 2020 and reported on this Form 4, subject to vesting as set forth in footnote (1) and will be settled into common stock upon vesting; and (ii) 70,000 shares of common stock owned by the reporting person."}],"balance_after":77500,"source":{"system":"sec-edgar","filing":"0001193805-20-000289","document":"e619423_4-guiheen.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/e619423_4-guiheen.xml","form_type":"4"}},{"id":3279388,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-11T15:18:25.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":20000,"price":3.5,"value":70000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the Issuer's public offering."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001193805-20-000135","document":"e619337_4-guiheen.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/e619337_4-guiheen.xml","form_type":"4"}},{"id":3516539,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-21T11:13:31.000Z","date":"2019-05-17","kind":"purchase","acquired":true,"shares":25000,"price":4,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the Issuer's public offering."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001193805-19-000523","document":"e618482_4-guiheen.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/e618482_4-guiheen.xml","form_type":"4"}},{"id":3592422,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-03-15T21:02:30.000Z","date":"2019-03-13","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option terminates on the earlier of (i) March 13, 2029 and (ii) the one-year anniversary of the reporting person's ceasing to serve as a director of the Issuer."}],"balance_after":30000,"derivative":{"exercise_price":3.89,"expiration_date":"2029-03-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193805-19-000297","document":"e618307_4-guiheen.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380519000297/e618307_4-guiheen.xml","form_type":"4"}},{"id":3883851,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-25T21:00:56.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twenty-four equal monthly installments, becoming fully vested on the two year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option terminates on the earlier of (i) June 22, 2028 and (ii) the one year anniversary of the reporting person's ceasing to serve as a director of the Issuer."}],"balance_after":17500,"derivative":{"exercise_price":4.91,"expiration_date":"2028-06-22","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001193805-18-000902","document":"e618127_4-guiheen.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380518000902/e618127_4-guiheen.xml","form_type":"4"}},{"id":3898047,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T11:09:14.000Z","date":"2018-06-08","kind":"purchase","acquired":true,"shares":20000,"price":4.78,"value":95600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the Issuer's public offering."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001193805-18-000819","document":"e618085_4-guiheen.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380518000819/e618085_4-guiheen.xml","form_type":"4"}},{"id":4288067,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-08T22:04:08.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":53837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twenty-four equal monthly installments, becoming fully vested on the two year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option terminates on the earlier of (i) June 6, 2027 and (ii) the one year anniversary of the reporting person's ceasing to serve as a director of the Issuer."}],"balance_after":53837,"derivative":{"exercise_price":3.66,"expiration_date":"2027-06-06","underlying":"Common Stock","underlying_shares":53837},"source":{"system":"sec-edgar","filing":"0001193805-17-001060","document":"e616267_4-guiheen.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380517001060/e616267_4-guiheen.xml","form_type":"4"}},{"id":4442120,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":59868,"kind":"person","name":"Guiheen Lawrence P.","position":1,"cik":"0001554353","reported_name":"Guiheen Lawrence P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-17T01:30:21.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twenty-four equal monthly installments, becoming fully vested on the two year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option terminates on the earlier of (i) February 14, 2027 and (ii) the one year anniversary of the reporting person's ceasing to serve as a director of the Issuer."}],"balance_after":10000,"derivative":{"exercise_price":5,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193805-17-000282","document":"e615795_4-guiheen.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380517000282/e615795_4-guiheen.xml","form_type":"4"}}]}